Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines-Reference-Cited by-同舟云学术

Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines

Published:2007-12-07 Issue:1 Volume:14 Page:142-144
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:

Author:

NEUGEBAUER B.,DRAI C.,HAASE M.,HILGER A.,KELLER-STANISLAWSKI B.,LAITINEN-PARKKONEN P.,MENTZER D.,RASMUSSEN C.,RATIGNIER C.,SEITZ R.

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2007.01604.x/fullpdf

Reference5 articles.

1. EMEA Report of the Expert Meeting on Factor VIII Products and Inhibitor Development http://www.emea.europa.eu/pdfs/human/bpwg/12383506en.pdf

2. Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate;Peerlinck;Thromb Haemost,1997

3. EMEA Public Statement: Review of Recombinant Factor VIII (FVIII) Products and Inhibitor Development http://www.emea.europa.eu/pdfs/human/press/pus/33131605en.pdf

4. Développement des inhibiteurs et prise en charge chez les patients hémophiles traités par facteur VIII ou IX d’origine plasmatique ou recombinante http://afssaps.sante.fr/pdf/5/dev-inhibiteur-hemophile-facteur8.pdf

5. EMEA Guideline on Risk Management Systems for Medicinal Products for Human Use http://www.emea.europa.eu/pdfs/human/euleg/9626805en.pdf

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Retrospective Study of the Cytokine Profile Changes in Mice with FVIII Inhibitor Development After Adeno-Associated Virus–Mediated Gene Therapy in a Hemophilia A Mouse Model;Human Gene Therapy;2018-03

2. The growing number of hemophilia registries: Quantity vs. quality;Clinical Pharmacology & Therapeutics;2015-04-03

3. Comment on: Mannucci, P. M. Evolution of the European guidelines for the clinical development of factor VIII products;Haemophilia;2013-04-19

4. Clotting factor concentrate switching and inhibitor development in hemophilia A;Blood;2012-07-26

5. Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies;Journal of Thrombosis and Haemostasis;2011-11